AVECOR Cardiovascular's Affinity oxygenator:
This article was originally published in Clinica
The FDA has given US company AVECOR Cardiovascular 510(k) marketing clearance for its Affinity oxygenator with Trillium bio-passive surface. All blood-contact surfaces of oxygenators are coated with a non-leaching synthetic hydrophilic polymer containing a small amount of heparin. The bio-passive surface minimises activation of blood constituents which would occur as a result of contact with this synthetic coating.
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.